Abstract
This paper covers the regulatory environment in Japan. The “Basic Policies for Approval to Manufacture Drugs” adopted by the Ministry of Health and Welfare in 1967 is described in detail. Pharmaceutical retail outlets in Japan are explained. Topics of interest: prescription to over-the-counter switches, Kampo or Chinese medicines, and consumer attitudes toward nonprescription medicines are covered.
Keywords
Get full access to this article
View all access options for this article.